Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.0B | 1.2B | 1.1B | 968.2M |
| Cost of revenue | 575.6M | 688.5M | 582.1M | 543.5M |
| Gross profit | 445.0M | 512.6M | 480.1M | 424.7M |
| Operating expense | ||||
| Research & development | 184.6M | 185.4M | 178.8M | 175.5M |
| Selling general and admin | 318.2M | 366.3M | 337.0M | 320.5M |
| Other operating expenses | — | — | — | — |
| Operating income | -57.7M | -39.1M | -35.8M | -71.2M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 433K | — | — | — |
| Other income expense | 17.6M | 13.7M | 30.9M | 28.1M |
| Pretax income | -40.5M | -25.9M | -4.9M | -43.1M |
| Tax provision | -13.1M | 9.7M | 4.1M | -9.2M |
| Net income | -27.4M | -35.5M | -9.0M | -34.0M |
| Basic EPS | -0.2 | -0.2 | -0.1 | -0.2 |
| Diluted EPS | -0.2 | -0.2 | -0.1 | -0.2 |
| Basic average shares | 146.2M | 145.6M | 144.9M | 144.3M |
| Diluted average shares | 146.2M | 145.6M | 144.9M | 144.3M |
| EBITDA | 34.7M | 156.7M | 42.4M | 16.6M |
| Net income from continuing op. | -27.4M | -35.5M | -9.0M | -34.0M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |